BRITANNIA LIFE SCIENCES (L020) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BRITANNIA LIFE SCIENCES (L020) has a cash flow conversion efficiency ratio of 0.057x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€989.01K ≈ $1.16 Million USD) by net assets (€17.23 Million ≈ $20.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BRITANNIA LIFE SCIENCES - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how BRITANNIA LIFE SCIENCES's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read BRITANNIA LIFE SCIENCES (L020) total liabilities for a breakdown of total debt and financial obligations.
BRITANNIA LIFE SCIENCES Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BRITANNIA LIFE SCIENCES ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cadoux Ltd
AU:CCM
|
-0.014x |
|
HUIJING HLDG.CO.LTD HD-01
F:3XU
|
N/A |
|
Torr Metals Inc
V:TMET
|
-0.067x |
|
WebRock Ventures AB
ST:WRV
|
-0.007x |
|
Alkali Metals Limited
NSE:ALKALI
|
0.042x |
|
TMM REAL EST.DEV.GDR S 1
F:TR61
|
N/A |
|
Mathios Refractories S.A.
AT:MATHIO
|
0.009x |
|
Ajooni Biotech Limited
NSE:AJOONI
|
0.149x |
Annual Cash Flow Conversion Efficiency for BRITANNIA LIFE SCIENCES (2022–2025)
The table below shows the annual cash flow conversion efficiency of BRITANNIA LIFE SCIENCES from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see L020 market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | €6.30 Million ≈ $7.37 Million |
€-2.62 Million ≈ $-3.06 Million |
-0.416x | -232.59% |
| 2024-03-31 | €6.67 Million ≈ $7.80 Million |
€2.09 Million ≈ $2.45 Million |
0.314x | +72.71% |
| 2023-03-31 | €11.06 Million ≈ $12.93 Million |
€2.01 Million ≈ $2.35 Million |
0.182x | -64.44% |
| 2022-03-31 | €5.48 Million ≈ $6.41 Million |
€2.80 Million ≈ $3.27 Million |
0.511x | -- |
About BRITANNIA LIFE SCIENCES
Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. It serves cosmetics, consumer packaged and household goods, and nutraceutical industries. The company is headquartered in Toronto, Canada.